Studies have shown that RBP4 can lead to insulin resistance and affect protein anabolism in skeletal muscle indirectly, particularly under the stimulation of peroxisome proliferator-activated receptor-gamma (PPARγ) agonists [41]. The gene discussed is PPARG; the disease is Insulin resistance.